Education

What Really Helps in Menopause: Prevention, Treatment, and the New Science

Published October 2, 2025
Author: Maria Corlianò, PhD
Last week, we mapped what tends to change after menopause, and why. This week is the practical follow-through: what women can do about it, from daily habits that move the needle to medications and devices with solid evidence, plus a peek at new therapies in the pipeline. Along the way, we’ll answer a hot question upfront: Is anything clinically proven to delay natural menopause in healthy women? (Short answer: no, not yet. But researchers (including us at the LSF) are working on it; we’ll explain what’s experimental and why.)
This chapter is not medical advice, but it provides some guidelines to help you talk with your clinician and make practical choices that fit your real life.

What does “prevention” mean after the estrogen reset

When estradiol falls, many systems lose a layer of maintenance. “Prevention” here doesn’t mean dodging menopause; it means lowering the risk and intensity of downstream problems, including heart and vessel disease, rapid bone loss, metabolic drifts, sleep fragmentation, urogenital symptoms, joint pain, moisture barrier dryness, and even cancer and neurodegenerative disorders.
Three pillars amplify almost every intervention:
  • Muscle as medicine. Resistance training preserves bone, improves glucose control, stabilizes joints, and improves sleep quality.

  • Cardio that you’ll actually do. Regular brisk walking or cycling supports vascular health and blood pressure.

  • Sleep as infrastructure. Consistent schedules, a cool/dark room, and morning light help. For entrenched insomnia, a specialised therapy (CBT-I) is first-line and durable.
These are not “nice-to-haves.” They’re the base that makes medications work better and symptoms easier to live with.

Menopausal hormone therapy (MHT/HRT): when it helps, how to do it safely

HRT is both hopeful and controversial. We’ve already covered the backstory in detail in previous articles, including the 2003 FDA black-box warning after early risks were reported, and the 2025 advisory panel’s unanimous recommendation to remove that warning in light of newer formulations, routes, and timing, along with why some experts still urge caution pending more modern, large trials. You’ll find that explainer here: [link].
That said, systemic estrogen, with a progestogen if you have a uterus, prevents bone loss and fractures and it is the most effective treatment for vasomotor symptoms (hot flashes and night sweats); when these episodes disrupt sleep, it often helps there too. For genitourinary symptoms such as dryness, pain with sex, or urgency, low-dose vaginal estrogen is highly effective with minimal body-wide absorption.
For women younger than 60 or within ~10 years of the final period without contraindications, the benefit-to-risk ratio is favorable for symptom control and bone protection. Risks vary by dose, route (patch vs pill), and whether a progestogen is used. This “window” is why your clinician asks not just “how do you feel?” but also “how long since your last period?”
If you can’t or don’t want hormones, keep reading; there are proven non-hormonal options for each symptom cluster.

Hot flashes & night sweats: proven non-hormonal options

If hot flashes and night sweats do not leave you alone, two classes have strong evidence:
  • Neurokinin-3 (NK3) receptor antagonists. Fezolinetant is an FDA-approved, non-hormonal pill for moderate to severe vasomotor symptoms. It works centrally on the brain’s temperature control and reduces hot-flash frequency and severity; ongoing clinical data continue to support efficacy and tolerability. Another NK3 blocker, elinzanetant, has approvals outside the U.S. and is under extended FDA review [1-4].

  • Certain antidepressants, notably low-dose SSRIs/SNRIs (e.g., paroxetine, venlafaxine), plus gabapentin or oxybutynin can help. Your clinician can match options to your health profile (these are long-standing, guideline-supported choices).
Instead, be cautious about stellate ganglion block (an outpatient nerve block), which has promising, emerging trial data for hot flashes, but is limited. Therefore, it’s best considered only under a specialist’s supervision and informed consent [5].

Genitourinary symptoms (dryness, pain with sex, urgency, recurrent UTIs)

When it comes to genitourinary symptoms, local therapies are effective and underused:
  • Vaginal moisturizers/lubricants can provide immediate relief.

  • Low-dose vaginal estrogen or vaginal DHEA (prasterone) rebuilds tissue health; ospemifene (an oral SERM) is another effective option with endometrial-safety data. These are well-studied and guideline-endorsed [6,7].
When you’re dealing with genitourinary symptoms’ relief, be wary of lasers/"rejuvenation" devices. Multiple medical societies and the FDA have warned against energy-based vaginal procedures, given low-quality evidence and reports of harm (burns, scarring). If you’re offered a laser, ask for high-quality, long-term data; most women will do better with the proven options above [8,9].
Instead, pelvic floor physiotherapy remains a powerful, underused tool for leakage, pain, and confidence.

Bones: protecting strength, avoiding fractures

Without even blinking, the first steps in this case include strength training (2-3× weekly), adequate calcium and vitamin D, and fall-proofing your environment.
However, if your fracture risk is high, your clinician may recommend medication such as:
  • Antiresorptives, which slow bone breakdown: bisphosphonates and denosumab.

  • Anabolics, which build new bone in those at highest risk: teriparatide/abaloparatide/romosozumab.
Systemic estrogen also prevents bone loss when started in the appropriate window; your clinician will weigh this against your symptom profile and risks.
But, most importantly, get a DEXA scan on the recommended schedule so you’re treating your numbers and personal risk, not just your birthday, and adjusting the plan as those numbers change.

Metabolism: keeping glucose and lipids on your side

After menopause, insulin can be less effective, fat tends to shift toward the belly, and triglycerides and blood pressure often creep up. (This cluster is metabolic syndrome).
What works in this case is a combination of factors, starting from the easiest and most affordable interventions:
  • Resistance training is non-negotiable; muscle is your best glucose sink. When you lift, push, or pull against resistance, your muscles open more “doors” to pull sugar out of the bloodstream and store it as glycogen. That effect shows up in the very first workout and lasts for a day or two, so regular sessions steadily improve insulin sensitivity. More muscle also means more places to park glucose all day long, even when you are resting.

  • Protein spread across meals and fiber-rich, minimally processed foods smooths glucose swings. In simple terms, protein slows how quickly carbohydrate leaves your stomach and signals fullness, which keeps peaks and crashes in check, and fiber does the same by forming a gentle “mesh” that slows absorption in the gut. The best strategy is to pair them in balanced meals.

  • If needed, medications ranging from metformin to GLP-1 receptor agonists and SGLT2 inhibitors can support weight, glucose, and even heart and kidney protection; the “right” choice depends on goals, side effects, and cost. As always, talk with your clinician about coverage and benefits.

Sleep: the keystone that stabilizes everything else

If night sweats are waking you, fixing the vasomotor symptoms, whether with hormone therapy or non-hormonal options, often settles sleep on its own. But, when insomnia sticks around even after flushes are controlled, the best next step is CBT-I, which consistently beats sleep pills over the long haul with fewer downsides.
CBT-I (Cognitive Behavioral Therapy for Insomnia) is a short, structured program, usually 4 to 8 weeks, that retrains your sleep system. You’ll learn to rebuild a strong brain link between bed and sleep (go to bed only when sleepy, get up at the same time daily, keep the bed for sleep and intimacy), gently compress and then expand time in bed so sleep becomes deeper and more efficient, quiet the “sleep anxiety” loop with simple thought tools, anchor your body clock with morning light and consistent routines, and use relaxation skills that actually work at 3 a.m. It’s delivered by trained clinicians or via high-quality digital programs, and most people notice better sleep within a couple of weeks, with gains that last [10].
If you wake unrefreshed or you notice gasps, pauses, or mouth breathing, ask about sleep apnea. It becomes more common after menopause and can quietly raise blood pressure, flatten mood, and fog memory. A home sleep test is often enough to diagnose it, and treating apnea (for example, with CPAP or oral devices) can transform daytime energy and cardiovascular risk [11].

Joints & everyday pain

As estrogen dips, the cells that maintain cartilage slow their ‘repair and polish’ work, and the joint lining often makes thinner, less slippery joint fluid, so joints feel drier and creakier. At the same time, midlife muscle loss means less shock absorption, so more force hits the joint surfaces with each step or stair.
The fix is to rebuild the support system around the joint and keep it moving:
  • Strength training 2–3 times a week offloads knees and hips by letting muscles do more of the work. Adding simple range-of-motion drills (gentle bends, extensions, hip circles, ankle rotations) keeps the glide layer healthy.

  • Topical anti-inflammatories can calm flare-ups without sedating you. If you pair that with smart pacing, including shorter, more frequent sessions, supportive footwear, and, if needed, a few kilos of weight loss to reduce joint load, most activity-linked pain eases.
In this case, the rule of thumb is “move more, wisely”: progress gradually, favor good form over heavy weight, and let mild, short-lived soreness guide the next step rather than stopping you altogether.

Skin, eyes, and mouth

With less estrogen signaling, collagen renewal slows and your body’s “moisture barriers” don’t seal as well, so skin dries and thins, eyes feel sandy, and gums can creep back a little.
You don’t need fancy fixes; the basics done well:
  • Wear daily sunscreen (SPF 30+), cleanse gently, and rebuild the skin barrier with moisturizers that include ceramides, glycerin, or hyaluronic acid; at night, seal with a simple ointment on the driest spots.

  • Keep indoor air a bit more humid and limit long, hot showers. For dry eyes, add blink breaks when on screens, use warm compresses and lid hygiene, and start with preservative-free artificial tears; if symptoms persist, ask about prescription drops (e.g., cyclosporine or lifitegrast) or punctal plugs.

  • Protect your mouth with a soft brush, fluoride toothpaste, and daily floss or interdental brushes; regular cleanings catch early gum changes, and xylitol gum or saliva substitutes can ease dryness.
Small, steady habits like these restore comfort and function far better than chasing “miracle” products.

What screening actually does for you: from cancer to neuronal disorders

Menopause doesn’t “cause” cancer, but postmenopausal shifts in hormones, inflammation, and metabolism change the risk map for certain cancers. In this case, screening matters because it catches problems early. So, keep up with mammograms, cervical screening as recommended, and colon screening at the right age. If you have a strong family history, ask about genetic counseling and turn vague worry into a plan.
Similarly, some neurological disorders like Alzheimer’s and multiple sclerosis (MS) aren’t caused by menopause, but the drop in estrogen removes some of the brain’s “maintenance” signals at the same time midlife vascular and metabolic risks (blood pressure, glucose, sleep apnea) tend to rise. That combo can tip the odds for future cognitive decline, and in MS, some women notice more day-to-day fatigue or functional change around this life stage even if relapses are less frequent. The same levers you’re already using, controlling blood pressure and lipids, building and using muscle, prioritizing sleep and treating apnea, staying mentally and socially active, are protective here too. If MS is on your chart, loop your neurologist into any menopause treatments (including HRT) so care stays coordinated.

Is anything proven to delay natural menopause?

For healthy women, no approved therapy currently exists to delay the timing of natural menopause. Lifestyle associations (dietary patterns, smoking cessation) may nudge timing a bit in population studies, but there is no validated, prescribable intervention that reliably pushes menopause later for the average woman. Professional guidance today focuses on treating symptoms and reducing disease risk, not postponing menopause itself.
What’s experimental (and why it’s not ready):
  • Ovarian tissue cryopreservation with later re-implantation. Originally developed to preserve fertility during cancer treatment, some groups are exploring it to delay menopause in healthy women. It’s experimental, invasive, and we won’t know durability or risks for years [12].

  • mTOR inhibition (rapamycin) and other “ovarian aging” targets. Early-stage human studies (e.g., the VIBRANT trial) and preclinical work are probing whether low-dose rapamycin can slow depletion of ovarian follicles. This is research, not a clinical recommendation [13].

  • Cell and gene approaches/senolytics. Startups and academic labs are testing ways to support ovarian tissue or clear “aged” cells; none are proven for public use.
Bottom line: delay strategies are intriguing but speculative. If you see “delay menopause now” marketing, ask for peer-reviewed, long-term human data and regulatory approval, and assume it’s experimental unless proven otherwise. But, don’t worry, this is the research we are working on right now. With additional funding, we’ll begin to uncover just how we can delay menopause, and as a byproduct a number of the symptoms and risk factors we’re discussing today. Contact us to get involved.

The “watch list”: near-term advances to keep an eye on

  • NK3 antagonists as a class. With Fezolinetant already FDA-approved and Elinzanetant gaining approvals in other countries and under U.S. review, non-hormonal options for hot flashes are expanding quickly.

  • Tissue-selective estrogen complexes/newer SERMs. They aim to relieve symptoms with more targeted tissue effects (follow guidance from The Menopause Society as new data arrive) [14].

  • Better Genitourinary Syndrome of Menopause (GSM) regimens. Strong ongoing data for Ospemifene and vaginal DHEA versus placebo, with head-to-head and long-term safety building [6,7].
What’s not on the watch list are the energy-based vaginal “rejuvenation” devices, which remain not recommended for GSM due to safety and efficacy concerns [8,9].

Your actionable checklist (start today)

  • Track for 2-4 weeks: sleep, mood, hot flashes/night sweats, energy, pain, and any leakage. Bring notes to your visit. Simply, pick one change to test (small, specific), and ask for a 4-6 week plan with a set follow-up.

  • Heart & vessels: log home blood pressure; review lipids; choose walking/cardio you’ll actually do.

  • Bones: begin a simple strength routine (2–3×/week); confirm DEXA timing; discuss first-line bone meds if your risk is high.

  • Pelvic comfort: try local therapy (moisturizer/low-dose vaginal estrogen or DHEA) and request pelvic physio.

  • Sleep: cool/dark room, consistent schedule, morning light; consider CBT-I and screen for sleep apnea if you wake unrefreshed.

  • Metabolism: spread protein across meals, add fiber-rich foods, and schedule two resistance sessions weekly; review glucose/HbA1c with your doctor.

  • Hot flashes: if hormones aren’t for you, ask about fezolinetant (or, depending on your country, elinzanetant) or evidence-based alternatives.

Final word

Too often, women are told “it’s just menopause,” or handed conflicting advice and sent home. Access, cost, and culture shape care as much as biology. Menopause changes the rules of the game, not your ability to play. Today’s toolkit is stronger than most women have been told, and tomorrow’s looks even better. Focus on what’s proven, be cautious with what’s hyped, and build a plan you can live with. And if you want a second set of eyes or help tailoring next steps, reach out to the LSF. We’re here to turn evidence into practical guidance you can use. If you’re wondering whether you’re “doing it right,” you are, as long as you’re doing it on purpose.

References

  1. U.S. Food and Drug Administration. (2023, May 12). FDA approves novel drug to treat moderate to severe hot flashes caused by menopause. https://www.fda.gov/news-events/press-announcements/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause
  2. Elendu, C., Okahia, T. W., Blewusi, G. S., Meduoye, O. O. M., Ogelle, E. C., Egbo, A. R., … Olanlege, A. M. (2025). FDA approves Veozah (fezolinetant) for menopausal symptoms: A new nonhormonal option. Annals of Medicine and Surgery (Lond), 87(9), 5373–5377. https://doi.org/10.1097/MS9.0000000000003670 (PMCID: PMC12401328).
  3. Shapiro, M., et al. (2025). Treating moderate to severe menopausal vasomotor symptoms with fezolinetant: Responder analysis of the phase 3b DAYLIGHT study. Maturitas. Advance online publication. https://pmc.ncbi.nlm.nih.gov/articles/PMC12097698/
  4. Reuters. (2025, July 25). US FDA extends review of Bayer’s menopause relief drug. https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-extends-review-bayers-menopause-relief-drug-2025-07-25/
  5. Li, Y., et al. (2023). Effects of stellate ganglion block on perimenopausal hot flashes: A systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1293358 (PMCID: PMC10715304).
  6. StatPearls. (2025). [NCBI Bookshelf chapter]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK603644/ (Use chapter title and authors from the page when you finalize your bibliography.)
  7. Marchetti, G., et al. (2024). Ospemifene for genitourinary syndrome of menopause. International Journal of Women’s Health. https://doi.org/10.2147/IJWH.S431520 (PMCID: PMC11162622).
  8. Gunter, J. (2023). Genitourinary Syndrome of Menopause and the false promise of vaginal laser therapy. JAMA Network Open, 6(2), e2255706. https://doi.org/10.1001/jamanetworkopen.2022.55706
  9. Kaunitz, A. M., Pinkerton, J. V., & Manson, J. E. (2019). Women harmed by vaginal laser for treatment of GSM—the latest casualties of fear and confusion surrounding hormone therapy. Menopause, 26(4), 338–340. https://doi.org/10.1097/GME.0000000000001313 (PMCID: PMC6435398).
  10. Ntikoudi, A., Owens, D. A., Spyrou, A., Evangelou, E., & Vlachou, E. (2024). The Effectiveness of Cognitive Behavioral Therapy on Insomnia Severity Among Menopausal Women: A Scoping Review. Life (Basel, Switzerland), 14(11), 1405. https://doi.org/10.3390/life14111405
  11. Drake, C. L., Kalmbach, D. A., Arnedt, J. T., Cheng, P., Tonnu, C. V., Cuamatzi-Castelan, A., & Fellman-Couture, C. (2019). Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. Sleep, 42(2), zsy217. https://doi.org/10.1093/sleep/zsy217
  12. Khattak, H., Malhas, R., Craciunas, L., Afifi, Y., Amorim, C. A., Fishel, S., Silber, S., Gook, D., Demeestere, I., Bystrova, O., Lisyanskaya, A., Manikhas, G., Lotz, L., Dittrich, R., Colmorn, L. B., Macklon, K. T., Hjorth, I. M. D., Kristensen, S. G., Gallos, I., & Coomarasamy, A. (2022). Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis. Human reproduction update, 28(3), 400–416. https://doi.org/10.1093/humupd/dmac003
  13. Snyder, A. (2025, July 4). Repurposed drug may delay menopause, slow ovarian aging. NIH Record. https://nihrecord.nih.gov/2025/07/04/repurposed-drug-may-delay-menopause-slow-ovarian-aging
  14. The Menopause Society. (2025). Position statements. https://menopause.org/professional-resources/position-statements
Spotlight: Longevity in Context Female & Hormonal Health Metabolic & Immune Health Cancer Exercise & Muscle